Early detection of FXS with methylation specific-quantitative melt analysis (MS-QMA) that targets CpG sites within the FMR1 intron 1 has been achieved using the DNA of newborn blood spots from birth in both sexes [28]. Here, FMR1 is linked to fragile X syndrome.